Clinical features and outcomes of small airway disease in ANCA ‐associated vasculitis
Respirology · 2024
DOI: 10.1111/resp.14611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, 2024. Verfasst von Peining Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Antibodies, Antineutrophil Cytoplasmic, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background and Objective To clarify the prevalence, features and outcomes of small airway disease (SAD) in a Chinese cohort with antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) related pulmonary involvement.
Methods
SAD was recorded when the manifestations of either centrilobular nodules or air trapping were observed according to CT scans, except for infection or other airway‐related comorbidities. Baseline and follow‐up data were collected retrospectively.
Results
Of the 359 newly diagnosed AAV patients with pulmonary involvement, 92 (25.6%) had SAD, including 79 (85.9%) cases of anti‐MPO‐ANCA positive, 9 (9.8%) cases of anti‐PR3‐ANCA positive and 2 (2.2%) cases of double positive. Patients with SAD were more likely to be younger, female, non‐smokers, have more ear–nose–throat (ENT) involvement, and have higher baseline Birmingham Vasculitis Activity Score (BVAS) compared to patients without SAD. Several AAV‐related SAD patients have improved lung function and CT scans after immunosuppressive therapy. Patients with SAD had a better prognosis compared to those without SAD. When dividing all patients into three groups: isolated SAD (only small airway involvements), SAD with other lower airway involvements, and non‐SAD, patients in the SAD with other lower airway involvements group had the highest risk of infection, while patients in the non‐SAD group had the worst long‐term outcomes. Similar results were observed in anti‐MPO‐ANCA positive patients when performing subgroup analyses.
Conclusion
SAD is a unique manifestation of AAV‐related lung involvement and exhibits distinct clinical features. It is vital to focus on SAD because of its association with prognosis and infection in AAV patients, especially in anti‐MPO‐ANCA positive patients. Moreover, SAD might represent a better response to immunosuppressors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
- Department of Radiology, Peking University First Hospital, Beijing, China.
- Department of Nephrology, Peking University First Hospital, Beijing, China.
ORCID-Profile: Peining Zhou
Zitieren
APA
Zhou, P., Gao, L., Li, Z., Que, C., Li, H., Ma, J., & Wang, G. (2024). Clinical features and outcomes of small airway disease in ANCA ‐associated vasculitis. Respirology. https://doi.org/10.1111/resp.14611
Vancouver
Zhou P, Gao L, Li Z, Que C, Li H, Ma J, et al. Clinical features and outcomes of small airway disease in ANCA ‐associated vasculitis. Respirology. 2024. doi:10.1111/resp.14611
BibTeX
@article{Zhou2024,
author = {Zhou, Peining and Gao, Li and Li, Zhiying and Que, Chengli and Li, Haichao and Ma, Jing and Wang, Guangfa},
title = {Clinical features and outcomes of small airway disease in ANCA ‐associated vasculitis},
journal = {Respirology},
year = {2024},
doi = {10.1111/resp.14611}
}
EUVIMED